Replies to post #28773 on Intellipharmaceutics International Inc. (IPCI)

[92649]

Doog, to net $25M to do the studies @ a share price of say $150, plus a warrant it will add 35M shares or double the fully diluted amount now to about 70M shares. That is if the PPS is as high as $1.50. So you are right 70M to 80M shares to net $25M to $30M.

Usually on a miss like this the PPS goes down .60% or so, which equates to $1.50 and with an announcement of dilution the PPS could go lower. Good thing they have income coming in and increasing.

[AngeloFoca]

It would take a miracle at this point in time for the FDA to over-rule the panels no vote...but that possibility definitely exists...

LOL... is that along the thinking that IPCI has a one in a million chance of getting FDA approval... So it does still have a chance!!!

I can't help but feel the same... just don't want to let go.

I think the path forward is to combine Rexista with PODRAS... partner it, and take it forward that way... via the Fast Track route.

Also partner Regabatin... they can be on the market end of 2018 when Lyrica (pregabalin) goes generic... I always felt Regabatin was/is the jewel in the crown.

Regabatin is the meat - XR Generics are the potatoes.